ID   DUS26_HUMAN             Reviewed;         211 AA.
AC   Q9BV47; D3DSV8; Q9BTW0;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   15-MAR-2017, entry version 133.
DE   RecName: Full=Dual specificity protein phosphatase 26;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=Dual specificity phosphatase SKRP3;
DE   AltName: Full=Low-molecular-mass dual-specificity phosphatase 4;
DE            Short=DSP-4;
DE            Short=LDP-4;
DE   AltName: Full=Mitogen-activated protein kinase phosphatase 8;
DE            Short=MAP kinase phosphatase 8;
DE            Short=MKP-8;
DE   AltName: Full=Novel amplified gene in thyroid anaplastic cancer;
GN   Name=DUSP26; Synonyms=DUSP24, LDP4, MKP8, NATA1, SKRP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), MUTAGENESIS OF CYS-152,
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15796912; DOI=10.1016/j.bbrc.2005.03.028;
RA   Vasudevan S.A., Skoko J., Wang K., Burlingame S.M., Patel P.N.,
RA   Lazo J.S., Nuchtern J.G., Yang J.;
RT   "MKP-8, a novel MAPK phosphatase that inhibits p38 kinase.";
RL   Biochem. Biophys. Res. Commun. 330:511-518(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), MUTAGENESIS OF CYS-152,
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16924234; DOI=10.1038/sj.onc.1209899;
RA   Yu W., Imoto I., Inoue J., Onda M., Emi M., Inazawa J.;
RT   "A novel amplification target, DUSP26, promotes anaplastic thyroid
RT   cancer cell growth by inhibiting p38 MAPK activity.";
RL   Oncogene 26:1178-1187(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17001450; DOI=10.1007/s11010-006-9313-5;
RA   Takagaki K., Shima H., Tanuma N., Nomura M., Satoh T., Watanabe M.,
RA   Kikuchi K.;
RT   "Characterization of a novel low-molecular-mass dual specificity
RT   phosphatase-4 (LDP-4) expressed in brain.";
RL   Mol. Cell. Biochem. 296:177-184(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Zama T., Aoki R., Murata M., Ikeda Y.;
RT   "Identification of a novel dual specificity phosphatase, SKRP3.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, MUTAGENESIS OF CYS-152, INTERACTION WITH HSF4, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16581800; DOI=10.1128/MCB.26.8.3282-3294.2006;
RA   Hu Y., Mivechi N.F.;
RT   "Association and regulation of heat shock transcription factor 4b with
RT   both extracellular signal-regulated kinase mitogen-activated protein
RT   kinase and dual-specificity tyrosine phosphatase DUSP26.";
RL   Mol. Cell. Biol. 26:3282-3294(2006).
CC   -!- FUNCTION: Inactivates MAPK1 and MAPK3 which leads to
CC       dephosphorylation of heat shock factor protein 4 and a reduction
CC       in its DNA-binding activity. Inhibits MAP kinase p38 by
CC       dephosphorylating it and inhibits p38-mediated apoptosis in
CC       anaplastic thyroid cancer cells. Can also induce activation of MAP
CC       kinase p38 and c-Jun N-terminal kinase (JNK).
CC       {ECO:0000269|PubMed:15796912, ECO:0000269|PubMed:16581800,
CC       ECO:0000269|PubMed:16924234, ECO:0000269|PubMed:17001450}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- SUBUNIT: Interacts with HSF4. {ECO:0000269|PubMed:16581800}.
CC   -!- INTERACTION:
CC       Q13137:CALCOCO2; NbExp=3; IntAct=EBI-2924519, EBI-739580;
CC       P04637:TP53; NbExp=9; IntAct=EBI-2924519, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Golgi apparatus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BV47-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BV47-2; Sequence=VSP_026406;
CC   -!- TISSUE SPECIFICITY: Brain. In the brain it is expressed
CC       ubiquitously except in the hippocampus. Expressed in embryonal
CC       cancers (retinoblastoma, neuroepithilioma and neuroblastoma) and
CC       in anaplatic thyroid cancer. {ECO:0000269|PubMed:15796912,
CC       ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:16924234,
CC       ECO:0000269|PubMed:17001450}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class dual specificity subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY902194; AAX07132.1; -; mRNA.
DR   EMBL; AB158288; BAD82942.1; -; mRNA.
DR   EMBL; AB237597; BAE46506.1; -; mRNA.
DR   EMBL; AB103376; BAD91015.1; -; mRNA.
DR   EMBL; AK055704; BAB70991.1; -; mRNA.
DR   EMBL; CH471080; EAW63392.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63393.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63394.1; -; Genomic_DNA.
DR   EMBL; BC001613; AAH01613.1; -; mRNA.
DR   EMBL; BC003115; AAH03115.1; -; mRNA.
DR   EMBL; BC067804; AAH67804.1; -; mRNA.
DR   CCDS; CCDS6092.1; -. [Q9BV47-1]
DR   RefSeq; NP_001292044.1; NM_001305115.1. [Q9BV47-1]
DR   RefSeq; NP_001292045.1; NM_001305116.1. [Q9BV47-1]
DR   RefSeq; NP_076930.1; NM_024025.2. [Q9BV47-1]
DR   UniGene; Hs.8719; -.
DR   PDB; 2E0T; X-ray; 1.67 A; A=61-211.
DR   PDB; 4B04; X-ray; 2.20 A; A/B/C/D=61-211.
DR   PDB; 4HRF; X-ray; 1.68 A; A/B/C/D=61-211.
DR   PDB; 5GTJ; X-ray; 2.00 A; A/B/C/D=39-211.
DR   PDBsum; 2E0T; -.
DR   PDBsum; 4B04; -.
DR   PDBsum; 4HRF; -.
DR   PDBsum; 5GTJ; -.
DR   ProteinModelPortal; Q9BV47; -.
DR   SMR; Q9BV47; -.
DR   BioGrid; 122457; 2.
DR   IntAct; Q9BV47; 7.
DR   STRING; 9606.ENSP00000256261; -.
DR   ChEMBL; CHEMBL2295562; -.
DR   DEPOD; Q9BV47; -.
DR   iPTMnet; Q9BV47; -.
DR   PhosphoSitePlus; Q9BV47; -.
DR   BioMuta; DUSP26; -.
DR   DMDM; 74752374; -.
DR   PaxDb; Q9BV47; -.
DR   PeptideAtlas; Q9BV47; -.
DR   PRIDE; Q9BV47; -.
DR   DNASU; 78986; -.
DR   Ensembl; ENST00000256261; ENSP00000256261; ENSG00000133878. [Q9BV47-1]
DR   Ensembl; ENST00000523956; ENSP00000429176; ENSG00000133878. [Q9BV47-1]
DR   GeneID; 78986; -.
DR   KEGG; hsa:78986; -.
DR   UCSC; uc003xjp.4; human. [Q9BV47-1]
DR   CTD; 78986; -.
DR   DisGeNET; 78986; -.
DR   GeneCards; DUSP26; -.
DR   HGNC; HGNC:28161; DUSP26.
DR   HPA; HPA018221; -.
DR   neXtProt; NX_Q9BV47; -.
DR   OpenTargets; ENSG00000133878; -.
DR   PharmGKB; PA142671921; -.
DR   eggNOG; KOG1716; Eukaryota.
DR   eggNOG; COG2453; LUCA.
DR   GeneTree; ENSGT00760000118853; -.
DR   HOGENOM; HOG000233767; -.
DR   HOVERGEN; HBG001524; -.
DR   InParanoid; Q9BV47; -.
DR   KO; K14165; -.
DR   OMA; YLMIRQN; -.
DR   OrthoDB; EOG091G0249; -.
DR   PhylomeDB; Q9BV47; -.
DR   TreeFam; TF105128; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   SIGNOR; Q9BV47; -.
DR   EvolutionaryTrace; Q9BV47; -.
DR   GenomeRNAi; 78986; -.
DR   PRO; PR:Q9BV47; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000133878; -.
DR   CleanEx; HS_DUSP26; -.
DR   ExpressionAtlas; Q9BV47; baseline and differential.
DR   Genevisible; Q9BV47; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IPI:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004647; F:phosphoserine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB.
DR   GO; GO:1902310; P:positive regulation of peptidyl-serine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   CDD; cd00127; DSPc; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR020417; Atypical_DUSP.
DR   InterPro; IPR020405; Atypical_DUSP_famA.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR024950; DUSP.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR10159; PTHR10159; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   PRINTS; PR01908; ADSPHPHTASE.
DR   PRINTS; PR01909; ADSPHPHTASEA.
DR   SMART; SM00195; DSPc; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Golgi apparatus; Hydrolase; Nucleus; Protein phosphatase;
KW   Reference proteome.
FT   CHAIN         1    211       Dual specificity protein phosphatase 26.
FT                                /FTId=PRO_0000292219.
FT   DOMAIN       61    206       Tyrosine-protein phosphatase.
FT   ACT_SITE    152    152       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   VAR_SEQ       1    125       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026406.
FT   MUTAGEN     152    152       C->A,S: Loss of activity.
FT                                {ECO:0000269|PubMed:15796912,
FT                                ECO:0000269|PubMed:16581800,
FT                                ECO:0000269|PubMed:16924234}.
FT   HELIX        45     54       {ECO:0000244|PDB:5GTJ}.
FT   STRAND       62     66       {ECO:0000244|PDB:2E0T}.
FT   STRAND       69     72       {ECO:0000244|PDB:2E0T}.
FT   HELIX        74     77       {ECO:0000244|PDB:2E0T}.
FT   HELIX        80     86       {ECO:0000244|PDB:2E0T}.
FT   STRAND       90     93       {ECO:0000244|PDB:2E0T}.
FT   TURN         98    100       {ECO:0000244|PDB:4HRF}.
FT   HELIX       106    109       {ECO:0000244|PDB:2E0T}.
FT   STRAND      112    115       {ECO:0000244|PDB:2E0T}.
FT   HELIX       127    142       {ECO:0000244|PDB:2E0T}.
FT   STRAND      148    151       {ECO:0000244|PDB:2E0T}.
FT   STRAND      153    156       {ECO:0000244|PDB:2E0T}.
FT   HELIX       157    170       {ECO:0000244|PDB:2E0T}.
FT   HELIX       175    184       {ECO:0000244|PDB:2E0T}.
FT   HELIX       192    207       {ECO:0000244|PDB:2E0T}.
SQ   SEQUENCE   211 AA;  23946 MW;  60E944304905086D CRC64;
     MCPGNWLWAS MTFMARFSRS SSRSPVRTRG TLEEMPTVQH PFLNVFELER LLYTGKTACN
     HADEVWPGLY LGDQDMANNR RELRRLGITH VLNASHSRWR GTPEAYEGLG IRYLGVEAHD
     SPAFDMSIHF QTAADFIHRA LSQPGGKILV HCAVGVSRSA TLVLAYLMLY HHLTLVEAIK
     KVKDHRGIIP NRGFLRQLLA LDRRLRQGLE A
//
